The cell culture market is expected to grow at 11.7% CAGR from 2023 to 2029. It is expected to reach above USD 51.59 billion by 2029 from USD 19.07 billion in 2022.
The technique of taking cells from an animal or plant source and growing them later under controlled circumstances is known as cell culture (in vitro). In addition, this artificial environment contains nutrients that are necessary for cell growth and multiplication, such as the right temperature, gases, pH, and humidity. Before culture, cells from the tissues can be removed mechanically or enzymatically. The cells that need to be cultivated can also come from an established cell line or cell strain.
Cell cultures are used to create biological products like recombinant proteins or antibodies or for in vitro tests. The culture media is typically supplemented with blood or a variety of specified chemicals to promote optimal cell growth.
Cell culture is the controlled cultivation of nucleated (eukaryotic) cells in a laboratory setting. Only in cell culture may infectious pathogens be isolated that need to replicate in living host cells. Cell culture is no longer commonly used for routine clinical diagnostic purposes due to the development of molecular diagnostic assays based on nucleic acid detection, as a result of the lengthy turnaround times (days to weeks), high cost, and requirement for significant technical expertise to perform cell culture and interpret results.
Global demand for 3D cell culture technology is growing as a result of recent advances in proteomic gene expression, innovative biopharmaceuticals, and vaccine development. The global cell culture market is expanding due to the increased incidence of cancer, the expansion of cancer research initiatives, and enhanced gene therapy applications. The market for cell culture is expanding thanks to the existence of numerous contract manufacturing and research companies. The prevalence of chronic diseases among the world's population is increasing, which has drawn funding for cytology and biology research studies.
| ATTRIBUTE | DETAILS |
| Study period | 2020-2029 |
| Base year | 2021 |
| Estimated year | 2022 |
| Forecasted year | 2022-2029 |
| Historical period | 2018-2020 |
| Unit | Value (USD Billion), (Kilotons) |
| Segmentation | By Product, By Application, By End use, By Region |
| By PRODUCT
|
|
| By Application
|
|
| By Region
|
|
Global demand for vaccines is anticipated to be fueled by the rising prevalence of infectious illnesses and the rising risk of pandemics. Cell culture has emerged as a significant component of vaccine development in the pharmaceutical business. To create vaccinations against rotavirus, polio, smallpox, hepatitis, rubella, and chickenpox, cell culture technology was employed. Additionally, many European nations and the US have approved the use of cell-based influenza vaccinations. The main elements anticipated to boost the growth of the cell culture market during the forecast period are rising awareness of the advantages of cell culture-based vaccinations and the regulatory approval of numerous cell culture-based vaccines globally.
The use of 3D cell cultures is more expensive to establish, and results are not always predictable. Lack of consistency will continue to be a significant market problem until they start. Additionally, it is anticipated that a scarcity of qualified labor and high technology costs will limit industry growth. Due to the fact that animal cells grow more slowly than many common pollutants, cell culture techniques require highly competent staff and careful asepsis procedures (e.g., bacteria, viruses and fungi).
The fundamental benefit of employing a batch of clonal cells is the uniformity and repeatability of the results. Cell cultures can precisely manage their physicochemical environment, including pH, temperature, osmotic pressure, oxygen tension, and carbon dioxide tension, as well as their physiological state, which can be monitored regularly.
Due to the crucial role cell culture technology played in the identification of innovative diagnostic and treatment options for the disease, the COVID-19 pandemic has increased the need for cell culture goods. For instance, studies targeted at understanding the mechanism of viral entry into host cells and high-throughput COVID-19 drug screening to identify new treatment candidates are anticipated to have a favorable impact on the market's growth. Additionally, culturing methods provide crucial resources for the creation of viral particles for vaccine research, expanding the field's growth prospects.
The enormous amount of money needed for cell culture research, followed by proving its efficacy, manufacture, and distribution, will impede the expansion of the market for cell culture products worldwide.
The cell culture market is expected to grow at 11.7% CAGR from 2022 to 2029. It is expected to reach above USD 51.59 billion by 2029 from USD 19.07 billion in 2020.
Asia Pacific held more than 55% of the Cell Culture market revenue share in 2021 and will witness expansion in the forecast period.
Global demand for 3D cell culture technology is growing as a result of recent advances in proteomic gene expression, innovative biopharmaceuticals, and vaccine development. The global cell culture market is expanding due to the increased incidence of cancer, the expansion of cancer research initiatives, and enhanced gene therapy applications. The market for cell culture is expanding thanks to the existence of numerous contract manufacturing and research companies.
Key companies in the global market include Bio-Radd laboratories, thermo fisher scientific inc, merck KGaA, VWR international LLC, Eppendorf SE, BioSpherixltd, becton, bio-techne corporation, cytiva, lonza group, avantor inc, agilent technologies.
Applications of the technology in vaccine production are projected to have a favorable impact on industry growth given the COVID-19 pandemic's acceleration of vaccine approval procedures and significant investments in vaccine production
Asia Pacific is the largest market in 2021 accounted for 55% revenue generation of worldwide sales. It is due to advancement in technology and advancement in manufacturing is the reason behind this. Due to the increase in knowledge surrounding the usage of cell culture techniques, Asia-Pacific offers attractive potential for the key players functioning in the cell culture market
The cell culture market is segmented based on product, applications and end user and Region, Global trends and forecast.
By type, the market is bifurcated into by product (equipment, consumables, ice), by application (cancer research, gene therapy, tissue culture, bioproduction, vaccines), by end use (research, pharma, hospitals, laboratories) and region, global trends and forecast.
In terms of Product, the consumables category dominated the worldwide cell culture market in terms of product. The financing for cell-based research has increased, which has greatly encouraged the use of consumables. One of the main causes of the increased demand for consumables worldwide is the quickly expanding number of biopharmaceutical firms, contract manufacturers, contract research organizations, and academic research institutes. Significant market expansion is being driven by the escalating demand for equipment among cell culture application development companies and research facilities. The adoption of automation and robots is anticipated to improve output and accelerate market expansion in the near future.
Based on applications, the cell culture market's largest portion belongs to the bioproduction sector. The use of cell culture goods for research and commercial bioproduction, the rising demand for pharmaceutical and biopharmaceutical products, and the accessibility of funding for research activities are the main drivers of this segment's substantial market share. Applications of the technology in vaccine production are projected to have a favorable impact on industry growth given the COVID-19 pandemic's acceleration of vaccine approval procedures and significant investments in vaccine production.
[caption id="attachment_14674" align="aligncenter" width="1920"]
Key companies in the global market include Bio-Radd laboratories, thermo fisher scientific inc, merck KGaA, VWR international LLC, Eppendorf SE, BioSpherixltd, becton, bio-techne corporation, cytiva, lonza group, avantor inc, agilent technologies.
06-02-2023: - Thermo Fisher Scientific, the world leader in serving science, and Celltrio, a leading manufacturer of robotics-based solutions for the life sciences industry, have announced their collaboration to bring a fully automated cell culture system to biotherapeutics customers.
24-01-2023: - Thermo Fisher Scientific partners with AstraZeneca to develop solid tissue and blood-based companion diagnostic test for tagrisso.
The cell culture market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
During the projected period, Asia Pacific is the largest market in 2021 accounted for 55% revenue generation of worldwide sales. It is due to advancement in technology and advancement in manufacturing is the reason behind this.
Due to the increase in knowledge surrounding the usage of cell culture techniques, Asia-Pacific offers attractive potential for the key players functioning in the cell culture market. A further driver of market expansion is the increase in regional research funding. In addition, it is anticipated that the major manufacturers' focus on increasing their geographic presence in the developing Asia-Pacific nations will propel the market for cell culture in the area. Asia-Pacific presents enticing potential for the major companies operating in the cell culture market because of the increased awareness surrounding the use of cell culture procedures. The growth in regional research funding is another factor influencing market expansion. Additionally, it's expected that the leading manufacturers' focus on expanding their geographic reach in the rising Asia-Pacific nations will fuel the region's cell culture market.
Due to large investments in research and development, the presence of an established scientific infrastructure, the high demand for media devoid of animal components, and other factors, North America is also anticipating the great rise in the cell culture market. Additionally, it is anticipated that continued research and the growth of the biopharmaceutical industry in the United States will accelerate industry growth in the region.
[caption id="attachment_14675" align="aligncenter" width="1920"]
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.